Who are spinosad topical suspension, 0.9%'s main competitors?

Direct comparators (same drug class / molecular target / therapeutic area): Succinylcholine Chloride, Nicotine (4 mg), Placebo Tablet and Nicotine Patch, propofol，remifentanil，cis atracurium, Nicotine Patch + Nicotine Gum, Anesthesia induction,propofol, remifentanil ,cisatracurium.

How often does this brief refresh?

Every 30 minutes from primary sources (FDA, EMA, MHRA, PMDA, ClinicalTrials.gov, USPTO). Subscribe to the RSS feed below for push alerts.

How do I get this as a recurring report?

Subscribe to /feed/ci/spinosad-topical-suspension-0-9.xml in any RSS reader (Feedly, Inoreader, NewsBlur). Every regulatory action, trial readout, or patent event lands in your feed automatically.

Last reviewed 2026-05-17 · How we verify

spinosad topical suspension, 0.9% — Competitive Intelligence Brief

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

spinosad topical suspension, 0.9% (spinosad topical suspension, 0.9%) competitive landscape: 6 comparators, recent regulatory actions, upcoming PDUFA, patent timeline. Class: Insecticide. Area: Entomology.

phase 3 Insecticide Nicotinic acetylcholine receptor Entomology Small molecule Live · refreshed every 30 min

Target snapshot

spinosad topical suspension, 0.9% (spinosad topical suspension, 0.9%) — ParaPRO LLC. Spinosad topical suspension works by activating nicotinic acetylcholine receptors in the insect nervous system, ultimately leading to the death of the insect.

Comparator set (6 drugs)

Auto-detected by same drug class / molecular target / therapeutic area, ranked by phase + recency. Override with ?vs=slug1,slug2,….

Drug	Generic	Sponsor	Phase	Class	Target	Approval / PDUFA
spinosad topical suspension, 0.9% TARGET	spinosad topical suspension, 0.9%	ParaPRO LLC	phase 3	Insecticide	Nicotinic acetylcholine receptor
Succinylcholine Chloride	SUXAMETHONIUM	Novartis	marketed	Depolarizing Neuromuscular Blocker	Muscle-type nicotinic acetylcholine receptor	1952-01-01
Nicotine (4 mg)	Nicotine (4 mg)	GlaxoSmithKline	marketed	Nicotinic acetylcholine receptor agonist	Nicotinic acetylcholine receptors
Placebo Tablet and Nicotine Patch	Placebo Tablet and Nicotine Patch	The Scripps Research Institute	marketed	Nicotine replacement therapy (NRT)	Nicotinic acetylcholine receptors
propofol，remifentanil，cis atracurium	propofol，remifentanil，cis atracurium	Tang-Du Hospital	marketed	General anesthetic combination (GABA agonist + opioid + neuromuscular blocker)	GABA-A receptor (propofol); mu-opioid receptor (remifentanil); nicotinic acetylcholine receptor at neuromuscular junction (cisatracurium)
Nicotine Patch + Nicotine Gum	Nicotine Patch + Nicotine Gum	University of Wisconsin, Madison	marketed	Nicotinic acetylcholine receptor agonist	Nicotinic acetylcholine receptors
Anesthesia induction,propofol, remifentanil ,cisatracurium	Anesthesia induction,propofol, remifentanil ,cisatracurium	Second Affiliated Hospital of Xi'an Jiaotong University	marketed	Anesthetic combination (GABA-A agonist, opioid, neuromuscular blocker)	GABA-A receptor (propofol), mu opioid receptor (remifentanil), nicotinic acetylcholine receptor at neuromuscular junction (cisatracurium)

Recent regulatory actions (last 90 days)

No regulatory actions in the last 90 days for this set.

Upcoming PDUFA dates (next 180 days)

No PDUFA dates in the next 180 days for this set.

Patent timeline (forward window)

No upcoming patent expiries for this set.

Sponsor landscape (Insecticide class)

ParaPRO LLC · 1 drug in this class

Subscribe to ongoing alerts

Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:

Cite this brief

Drug Landscape (2026). spinosad topical suspension, 0.9% — Competitive Intelligence Brief. https://druglandscape.com/ci/spinosad-topical-suspension-0-9. Accessed 2026-05-17.

Build your own brief

Pick any drug + add comparators:

https://druglandscape.com/ci/{slug} — auto-detected competitors
https://druglandscape.com/ci/{slug}?vs=drug1,drug2,drug3 — explicit comparators
Brand names auto-resolve: /ci/keytruda → 301 → /ci/pembrolizumab